Probiotics
The effectiveness of probiotics depends heavily on the specific strain and indication — there's no single universal 'best probiotic'.
Number of studies
2
Safety
Moderate
Time to effects
For antibiotic-associated diarrhea, effects can appear within a few days; for IBS support or general microbiome balance, clinical trials typically ran 4–8 weeks.
Monthly cost
ok. 40–90 zł/miesiąc
Price in Poland
40–90 zł za 30–60 kapsułek (miesiąc stosowania)
Who it's for
Preparaty wieloszczepowe z wyższym CFU i dojelitowym uwalnianiem są zwykle droższe niż jednoszczepowe.
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
The effectiveness of probiotics depends heavily on the specific strain and indication — there's no single universal 'best probiotic'.
- →Selected strains shorten the duration of infectious and antibiotic-associated diarrhea
- →Some strains support IBS (irritable bowel syndrome) symptoms in clinical trials
- →Possible support for mucosal immunity and reduced frequency of upper respiratory infections
| Group | Live microorganisms (lactic acid bacteria, yeasts) |
|---|---|
| Key strains | Lactobacillus rhamnosus GG, Saccharomyces boulardii, Bifidobacterium lactis/longum |
| Form | Capsules, sachets, fermented foods |
| Typical dose | 1–10 billion CFU/day, depending on strain |
| Evidence level | Moderate — strong for select strains and indications, preliminary beyond them |
| Interactions | Yes — antibiotics (leave a ~2 h gap) |
| Status | Dietary supplement / functional food, available over the counter |
Understand
Overview
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host — that's the official WHO/FAO definition, worth remembering because it highlights two key conditions: the microorganisms must be alive at the moment of consumption, and the dose (CFU, colony-forming units) must be the one actually documented in research.
The effects of probiotics are highly strain-specific, not just species- or genus-specific — meaning that results from studies on, say, Lactobacillus rhamnosus GG can't automatically be applied to a different Lactobacillus rhamnosus strain, let alone a different species altogether. This is one of the most commonly overlooked rules when consumers choose a probiotic supplement.
The fastest, most noticeable results go to people reaching for a probiotic for a specific, well-studied indication with a specific strain: patients taking antibiotics (e.g. Saccharomyces boulardii or Lactobacillus rhamnosus GG as protection against antibiotic-associated diarrhea), people with diagnosed IBS using a strain tested in that context, or travelers protecting themselves against traveler's diarrhea. A healthy person with no digestive complaints reaching for a random multi-strain product 'for general immunity' or 'for the microbiome' has a much lower chance of feeling anything measurable — evidence of benefit outside these narrow, well-studied indications remains preliminary. That's why choosing a probiotic is better guided not by the marketing-friendly genus name but by the specific strain printed on the label and its documented use.
Where it's found
The idea of deliberately consuming 'good' bacteria for health dates back to the early 20th century and Russian Nobel laureate Ilya Mechnikov, who linked the longevity of Bulgarian farmers who consumed large amounts of fermented milk to the lactic acid bacteria it contained. Traditional fermented foods found in cuisines around the world — kefir, yogurt, sauerkraut, kimchi — are a natural source of live bacterial cultures.
History of use
The term 'probiotic' entered scientific use in the 1960s, coined in opposition to 'antibiotic'. A key turning point was the shift from the general idea of 'good bacteria' to an approach based on a specific, isolated and studied strain — like Lactobacillus rhamnosus GG (isolated in 1985) or Saccharomyces boulardii (isolated in the 1920s) — which remains the scientific standard today.
Mechanism of action
Probiotics can compete with pathogens for binding sites in the intestinal epithelium and available nutrients, produce short-chain fatty acids (butyrate, propionate, acetate) that nourish intestinal epithelial cells, strengthen the gut barrier by increasing expression of tight-junction proteins, and modulate the local and systemic immune response through interaction with gut-associated lymphoid tissue (GALT).
Mechanisms also differ between specific strains: Lactobacillus rhamnosus GG adheres strongly to the intestinal mucosa and secretes biosurfactants that limit pathogen colonization; Saccharomyces boulardii — a yeast, not a bacterium — produces proteases that break down bacterial toxins and is naturally resistant to antibiotics; and Bifidobacterium strains, which physiologically dominate the infant gut, intensively ferment oligosaccharides into butyrate, the main energy source for colonocytes. This diversity of mechanisms explains why the effects of one strain can't be extrapolated to another — even within the same species.
Competition with pathogens
Selected strains occupy binding sites in the intestinal epithelium and consume available nutrients, making it harder for pathogenic bacteria to multiply.
Production of short-chain fatty acids
Fermentation of fiber and oligosaccharides produces butyrate, propionate and acetate, which nourish the cells of the intestinal epithelium.
Strengthening the gut barrier
Increased expression of tight-junction proteins limits the passage of toxins and pathogens through the intestinal wall into the bloodstream.
Modulation of the immune system
Interaction with gut-associated lymphoid tissue (GALT) affects the local and systemic immune response.
Gut-brain axis signaling
Bacterial metabolites may send signals to the central nervous system — a mechanism still at an early research stage in the context of mood.
Evidence: moderate — based on 2 studies in this database.
Benefits
Common myths
MythEvery probiotic works the same way, regardless of strain.
FactClinical effects are attributed to specific, studied strains, not entire bacterial species — it's worth checking whether a product contains a strain tested for the specific problem in question.
MythThe higher the CFU count, the better the probiotic.
FactThe CFU count matters less than the strain's survival through the digestive tract and its documented effect for a specific indication.
Forms & variants
Probiotics comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Lactobacillus rhamnosus GG
One of the most thoroughly studied strains in the world — the strongest evidence concerns prevention of antibiotic-associated diarrhea and infectious diarrhea in children.
Best for: Gut health, prevention of antibiotic-associated diarrhea
Saccharomyces boulardii
A probiotic yeast (not a bacterium) — naturally resistant to antibiotics, which allows it to be taken alongside antibiotic therapy without a time gap.
Best for: Protection during antibiotic therapy, traveler's diarrhea
Bifidobacterium lactis / longum
Strains that dominate the infant microbiome, studied in adults for support of bowel regularity and IBS symptoms.
Best for: Digestive comfort, support for bowel regularity
Multi-strain probiotics
Products combining several to a dozen strains — theoretically a broader spectrum of action, though not always studied as that specific combination (unlike single, well-documented strains).
Best for: General microbiome support when there's no specific clinical indication
Fermented foods (kefir, pickled vegetables, natural yogurt)
A natural source of live bacterial cultures, though usually without CFU standardization or a specific strain as in supplements.
Best for: Everyday, supplementary dietary support for the microbiome
Practice
Frequently asked questions
No — clinical effects are attributed to specific, studied strains, not entire bacterial species. When choosing a probiotic, it's worth checking whether the product contains a strain tested for the specific health problem in question.
It depends on the form — some modern products use microencapsulation technology that allows room-temperature storage, while others (especially older formulas) require refrigeration to preserve bacterial viability. It's worth checking the manufacturer's instructions.
It depends on the indication — for antibiotic-associated diarrhea, effects can appear within a few days, while for IBS support or general microbiome balance, clinical trials typically ran 4–8 weeks.
Dosage & timing
Typical dose
1–10 billion CFU/day, depending on the strain and indication (the dose described in the specific clinical trial for that product)
Form
Capsules, sachets or fermented foods with confirmed strain content
What matters is the specific, research-documented strain (e.g. Lactobacillus rhamnosus GG), not just the genus name.
Best times to take it
- As directed by the manufacturer — some strains require dosing on an empty stomach, others with a meal
Safety
Side effects & contraindications
Possible side effects
Bloating and gas in the first few days of use
Rarely: risk of infection in people with severely compromised immunity
Contraindications
Severe immunosuppression, critical illness — requires medical supervision
Interactions
Antibiotics — leave a 2 h gap between doses to limit elimination of the strain
Is it worth taking?
Who it's for
- People during or after antibiotic therapy (specific strains, e.g. Saccharomyces boulardii)
- People with IBS (irritable bowel syndrome) symptoms
- Travelers at risk of traveler's diarrhea
Not for
- Severe immunosuppression, critical illness — requires medical supervision
Evidence
Worth knowing
Saccharomyces boulardii is a probiotic yeast, naturally resistant to antibiotics — it can be taken alongside antibiotic therapy without a time gap.
With antibiotics, it's worth leaving a roughly 2-hour gap from bacterial probiotics to limit elimination of the strain.
Studies
A meta-analysis of clinical trial data found that selected probiotic strains significantly reduce the risk of antibiotic-associated diarrhea.
Hempel S, et al., JAMA, 2012
Probiotics for the prevention of antibiotic-associated diarrhea: a systematic review and meta-analysis
Moderate evidenceHempel S, et al. · JAMA · 2012
A meta-analysis showing a significant reduction in the risk of antibiotic-associated diarrhea with selected probiotic strains.
View studyEfficacy of probiotics in irritable bowel syndrome: a systematic review
Moderate evidenceFord AC, et al. · American Journal of Gastroenterology · 2018
A systematic review pointing to moderate improvement in IBS symptoms with probiotics, with significant heterogeneity between the strains studied.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.
26 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
47 publications on this site
Related entries
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.